Recall Register

Food, drugs, devices › Abiomed, Inc.

Device recall: lmpella CP with Smart Assist, Model Number: 0048-0003. Left heart support blood pump, for Use During Cardiogenic Shock a

FDA enforcement event 84025 · Class II · initiated 4 Sep 2019 · status Terminated · terminated 21 Jan 2020

DeviceVoluntary: Firm initiated1 product recordDanvers, MA

Abiomed, Inc. (Danvers, MA) initiated this device recall on 4 Sep 2019; FDA lists 1 product record under event 84025, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 968 device enforcement events initiated in 2019 carry the same class.

Status: Terminated, terminated 21 Jan 2020. Initiation: voluntary: firm initiated. Abiomed, Inc. has 30 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Abiomed, Inc., Danvers, MA.

Reason for recall

"This one pump shipped with incorrect pump programming, the initial production working version of the program. The pump would have immediately run at P9 for all selected P-levels, rather than a 10 second ramp up period. The pump may have migrated out of position and possibly caused injury. The positioning and suction alarms were also disabled."

Distribution

"The product was distributed to GA"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0345-2020lmpella CP with Smart Assist, Model Number: 0048-0003. Left heart support blood pump, for Use During Cardiogenic Shock and High-Risk PCI1Class IITerminated13 Nov 2019

Context

88%of 2019 device events are Class II968 events that year
1product record in this eventfirm median: 1
30events on this register for the firm

Other enforcement events for Abiomed, Inc.

InitiatedProduct (first record)TypeClassRecords
12 Aug 2026Automated Impella Controller (AIC) with the below product descriptions and corresponding Product Codes. 1. Impella ContrDeviceClass I3
11 Jun 2026ABIOMED Impella RP Flex with SmartAssist Set, Pump Set Code 1000323, containing Kit, 23Fr Introducer, 11cm, Sterile, 23 DeviceClass I13
22 May 2026Abiomed 14 Fr x 13 cm Low Profile Introducer Kit for Impella CP. Impella Set Product Code: 1000434. Introducer Product CDeviceClass I4
18 May 2026Impella CP Set with SmartAssist. Product Codes: 1000080, 1000851, 0048-0014, 0048-0024-JP.DeviceClass I1
14 May 2026Automated Impella Controller (AIC), for use with left heart support blood pump. Labeled as the following with correspondDeviceClass I1
20 Apr 2026Automated Impella Controller (AIC); Product Code: 0042-0000-US;DeviceClass I1
18 Feb 2026Purge Cassette, sold within Impella Pump Sets and Individually Packaged. Labeled and distributed in the below configuratDeviceClass I1
16 Feb 2026Automated Impella Controller (AIC), labeled as the following with corresponding Product Codes: 1. Impella Controller, PaDeviceClass I1
27 Jan 2026Impella RP with SmartAssist. Product Code: 0046-0035.DeviceClass I3
4 Dec 2025Impella 5.5 with SmartAssist¿ S2, Impella 5.5 with SmartAssist S2 Set, AU.DeviceClass II1

All 30 events for Abiomed, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "This one pump shipped with incorrect pump programming, the initial production working version of the program. The pump would have immediately run at P9 for all selected P-levels, rather than a 10 second ramp up period. The pump may have migrated out of position and possibly caused injury. The positioning and suction alarms were also disabled."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "The product was distributed to GA"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 21 Jan 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.